Chronic Progressive Lymphedema
CPL in horses can be a devastating disease. We're hoping that Cytowave will change that.
CPL in horses can be a devastating disease. We're hoping that Cytowave will change that.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Chronic</strong> <strong>Progressive</strong> <strong>Lymphedema</strong><br />
Treatment Case Study TIME LINE<br />
On April, 27th 2016, Cytowave treatments were started on a Friesian stallion for <strong>Chronic</strong> <strong>Progressive</strong> <strong>Lymphedema</strong><br />
(CPL). The following therapy report represents the first ninety (90) day case study period.<br />
All documentation was reported by Emily Jewell, owner of Keegan and Grace & Beauty Farms, and John Dovenmuehle,<br />
Cytowave Equine Therapy representative. Photographs taken by Emily Jewell.<br />
HISTORY OF SUBJECT:<br />
Horse: Keegan, Friesian stallion<br />
Age: 13 years old<br />
Height: 16.3 hands<br />
Weight: 1400 Lbs.<br />
Owners: Emily and Mike Jewell<br />
Grace and Beauty Farms<br />
Carlisle, IN.<br />
Environmental Conditions:<br />
Keegan kept in dry stall area. Stall is exceptionally neat and cleaned every day.<br />
Treatments are in the Farrier area of barn with Keegan standing on rubber pads.<br />
Exercise: Daily exercise in round pen. Clean dry area.<br />
Emily has owned Keegan since his birth and has trained him for show events and movies. He is considered a<br />
member of her family, which of course he is. Emily first noticed signs of CPL when Keegan was around 5-6 years<br />
old. Small nodules had appeared on Keegan’s rear legs, behind the hoofs. The symptoms spread from the right<br />
rear leg to the left rear leg, then progressed to the two front legs.<br />
The right rear leg has three (3) larger nodules and a large fold under the nodules. The left rear leg has two (2)<br />
larger nodules and a smaller fold under the nodules.<br />
The two front legs have small lesions with small nodules on both legs. The front legs are not in the trial program<br />
but we are observing them to see if there are improvements without treatment.<br />
OBJECTIVE:<br />
We determined that Keegan was in the second stages of the disease. Our first objective was to reduce inflammation<br />
by increasing circulation and lymphatic flow. We also wanted to relieve any soreness and pain in the rear<br />
legs and to make Keegan comfortable and give his body a chance to begin healing naturally.<br />
Currently Cytowave therapy does not have a pre-set program for CPL so we determined the best program would<br />
be aimed at controlling CPL by reducing inflammation. Treatments for this objective are to run continuously<br />
for two (2) weeks. We discussed the results of the treatments daily and based off of our results, set up the next<br />
treatments.